January 10-14, 2022
That’s a wrap on McDermott and EY at the 2022 J.P. Morgan Healthcare Conference! Thank you to all of our speakers and everyone who joined for the exclusive, virtual sessions with insights from industry leaders, innovators and investors from across the healthcare industry. If you were unable to attend live, you can still register to view the sessions on-demand. And you can find all the program details below. In the sessions, you’ll hear from healthcare leaders address the latest trends and implications across Digital Health, Life Sciences, Healthcare Private Equity (PE) and Hospitals and Health Systems (HHS). Use these insights to develop long-term, effective strategies for establishing deals and funding agreements to make a positive impact in 2022.


Prominent Speakers

Including executives from PE firms, investment banks, hospitals, health systems and other industry-leading organizations.

6 Substantive Programs

Exploring critical business and legal issues encountered by investors across the healthcare industry. Sessions will address emerging trends in Digital Health, Life Sciences, Healthcare Private Equity – including in Europe – Hospitals and Health Systems, and Health Technology Investing.

Content Here


Content Here


(All times in EST)

JANUARY 10, 2022

10:30 am – 12:45 pm 


Due to the rapid pace of change, life sciences companies are being forced to transform their business models, requiring greater focus on therapies or commercial models. Moving forward, companies will continue to use transactions as an important lever of transformation. This forum will address creative dealmaking strategies for growth in biopharma and medical technology as well as business model transformations companies should consider as they enter new deals.

JANUARY 11, 2022

11:00 am – 1:30 pm 


Advancements in digital health technology are driving greater innovation, with leaders looking to data and analytics as the future of patient care. Listen to executives from leading health technology companies for a series of fireside chats on the evolving models disrupting digital health, including the growing role that retail is playing in the space.

JANUARY 12, 2022

11:00 am – 2:00 pm 


Leading private equity investors will explore key drivers and trends across diverse industry subsectors, examining how shifting regulations and the 2022 midterm elections may alter the deal landscape, and mapping out strategies for adapting and thriving amid change. The panelists will also offer their exclusive insights into emerging opportunities in health IT and will forecast the next evolution of today’s hyper-competitive market.

JANUARY 12, 2022

2:00 – 3:15 pm

Digital health has never been hotter and investor interest is surging across all stages. From early- to late-stage investments, lines are blurring with increased disruption in the digital health landscape. During this forum, PE and VC leaders will share their approaches to investing in 2022 and beyond.

JANUARY 13, 2022

11:00 am – 1:00 pm 


Today’s hospitals and health systems face unprecedented levels of disruption. Hear from prominent health system executives as they share their perspectives on revenue growth strategies, novel partnerships and how the healthcare ecosystem is coming together more than ever before. These leaders will discuss developing trends and how to position your organization for growth to drive change in this fluid environment.

JANUARY 14, 2022

8:30 am – 9:30 am
Private equity executives from across Europe will address a number of key issues and opportunities for investors heading into 2022. They’ll share their experiences entering the US market and why it’s such an important expansion piece of their portfolio; discuss the rise in transatlantic deals in the healthcare space; and address the role of global collaborations for life sciences companies.
Guest Faculty
Rick Abramson, MD, MHCDS, FACR Chief Clinical Strategy Officer Covera Health
Mert Aktar Head of Corporate Development Kite, a Gilead Company
Garo Armen, PhD Chairman and Chief Executive Officer Agenus
David Berman Managing Partner Lorient Capital
Marco Bonaiti Vice President Apax Partners
Preston Brice Partner Grant Avenue Capital

Dan Brillman
Chief Executive Officer & Co-Founder
Unite Us

Christopher Cleary
Vice President, Corporate Development

Peter Connolly Managing Director, Head of North America Cobepa
Owen Davis Partner Martis Capital
John DiGiovanni Investment Partner Arsenal Capital Partners
Deborah Di Sanzo
Best Buy Health

Mike Drazin
Chief Financial Officer

Henry Elphick Deputy Chair, EHCPEA Chair, Mansfield Advisors

Dr. Adaeze Enekwechi
Operating Partner
Welsh, Carson, Anderson & Stowe

Melanie Fan Principal Ampersand Capital Partners
Rushika Fernandopulle Chief Innovation Officer One Medical
Brian Fortune Senior Managing Director Farragut Square Group
Kendall Garrison Partner TPG Capital
Adam Grossman Partner Deerfield
Alyssa Jaffee Partner 7wireVentures
Rohin Jain Managing Director H.I.G. Capital
John Kerins Managing Director Cain Brothers
Deborah Kilpatrick Co-Chief Executive Officer & Executive Chair Evidation
Barbara Krebs-Pohl Chief Integration Officer and SVP, Head of Global BD&L and Alliance Management MorphoSys

Tom Lee
Chief Executive Officer & Founder

Geoff Lieberthal Partner Two Sigma Impact
David Mishkin Senior Vice President Valtruis, A WCAS Company
Jason Mulvihill Chief Operating Officer and General Counsel American Investment Council
John Nguyen Chief Strategy Officer SSM Health
Stephen Parodi, MD
Executive Vice President of External Affairs, Communications and Brand
The Permanente Federation
J.P. Peltier
Global Group Head, Healthcare Investment Banking
Piper Sandler

Dr. Michelle Perugini
Chief Executive Officer & Co-Founder

Elizabeth Rockett Managing Director Kaiser Permanente Ventures
David Rhew, MD Global Chief Medical Officer & VP of Healthcare Microsoft
Sheri Shapiro Senior Vice President and Chief Strategy Officer Trinity Health
Rasu Shrestha, MD Executive Vice President and Chief Strategy andTransformation Officer Atrium
Glen Tullman Chief Executive Officer, Transcarent Founder & Managing Partner, 7wireVentures
Kristen Valdes Founder and Chief Executive Officer b.well Connected Health

Katherine Wood
TPG Capital

Asif Zaman Partner Public Pension Capital
Megan Zweig
Chief Operating Officer
Rock Health
McDermott Will & Emery
Stephen Bernstein Co-Chair of Digital Health McDermott Will & Emery
Jiayan Chen
McDermott Will & Emery
Ashley Fischer
McDermott Will & Emery
Brian Gordon
McDermott Will & Emery

McDermott Will & Emery

Fred Levenson Co-Head of Private Equity McDermott Will & Emery
Lisa Mazur Co-Chair of Digital Health McDermott Will & Emery
Mara McDermott Vice President McDermott+ Consulting
Vernessa Pollard Co-Chair of Life Sciences McDermott Will & Emery

McDermott Will & Emery

Jerry Sokol Global Head of Health McDermott Will & Emery
Dale Van Demark Co-Chair of Digital Health McDermott Will & Emery
Krist Werling Co-Head of Private Equity McDermott Will & Emery
John Babitt Partner, Life Sciences Ernst & Young LLP
Subin Baral Global Deals Leader, Life Sciences Ernst & Young LLP
Slavena Bardarova Principal EY-Parthenon
H. Mallory Caldwell US Health Leader Ernst & Young LLP
tony drabble Health & Life Sciences Sector Lead EY-Parthenon U.K.
Nigel Gault Chief Economist EY-Parthenon
Rachel Hall US Consulting Digital Health and Smart Health Experience Leader Ernst & Young LLP
Jeff McMahon Managing Director Ernst & Young Capital Advisors, LLC
Heather Meade Principal, Washington Council Ernst & Young
Kenny O’Neill Principal, Consulting, Digital Health Ernst & Young LLP
Dan Shoenholz Healthcare Private Equity Leader EY-Parthenon
Adam Sorensen US Health Integration and Divestiture Leader EY-Parthenon
Arda Ural Americas Industry Markets Leader, Health Sciences and Wellness Ernst & Young LLP
Event Partner
McDermott and EY are proud to partner with the Healthcare Private Equity Association (HCPEA).

For questions, please contact our Events Team.


Related Site:     McDermott+ Consulting

Attorney Advertising ©2023 McDermott Will & Emery